← The Wire
CYRXNasdaq
Cryoport, Inc.
Pharmaceutical Preparations · NV · CIK 1124524
Cryoport provides integrated, temperature-controlled supply chain solutions for life sciences, focusing on cell and gene therapies
$737M
Market cap
$16.28
Last close
+1.8%
1D
+10.2%
5D
965K
Volume
Price · last 39 sessions+59.5%
May 4L $10.21 · H $16.50Jun 29
358
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 9, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 4, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 202610-K10-KMar 5, 20268-KResults of OperationsMar 3, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 6, 20258-KAcquisition / Disposition · Reg FD DisclosureJun 13, 20258-KShareholder VoteJun 10, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KMaterial Agreement · Reg FD DisclosureMar 31, 202510-K10-KMar 7, 20258-KResults of OperationsMar 4, 2025SC 13GCRYOPORT, INC.Nov 14, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GSep 3, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 6, 20248-KCompany UpdateAug 6, 20248-KShareholder VoteMay 22, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 3, 2024DEF 14ADEF 14AApr 3, 202410-K10-KMar 13, 20248-KResults of OperationsMar 12, 20248-KExecutive Change · Company UpdateFeb 15, 2024SC 13GSC 13GFeb 14, 2024SC 13GMS INITIALFeb 8, 20248-KBylaw AmendmentNov 15, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 8, 20238-KResults of OperationsAug 9, 202310-Q10-QAug 9, 20238-KResults of OperationsJul 12, 20238-KShareholder VoteMay 16, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AMar 31, 2023DEF 14ADEF14AMar 31, 20238-KExecutive ChangeMar 28, 20238-KAuditor ChangeMar 15, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 23, 202310-Q10-QNov 4, 20228-KResults of OperationsNov 3, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 5, 20228-KShareholder VoteMay 5, 20228-KExecutive ChangeMar 21, 2022DEFA14ADEFA14AMar 18, 2022DEF 14ADEF 14AMar 18, 20228-KCompany UpdateMar 11, 2022SC 13GSC 13GMar 10, 202210-K10-KFeb 28, 20228-KResults of OperationsFeb 24, 20228-KCompany UpdateFeb 9, 20228-KCompany UpdateFeb 1, 20228-KMaterial Agreement · New Debt / ObligationNov 12, 2021424B5424B5Nov 12, 20218-KCompany UpdateNov 10, 20218-KCompany UpdateNov 8, 2021424B5424B5Nov 8, 202110-Q10-QNov 4, 20218-KResults of OperationsNov 4, 202110-Q10-QAug 6, 20218-KResults of OperationsAug 5, 202110-QFORM 10-QMay 6, 20218-KExecutive Change · Shareholder VoteMay 5, 20218-KResults of OperationsMay 4, 2021
Insider Activity
In the 90 days to Mar 23, 2026: 4 sold $471K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Shelton JerrellPresident, CEO | Sell | 2,894 | $8.18 | $24K |
| Mar 23, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 1,341 | $8.18 | $11K |
| Mar 23, 2026 | Stefanovich RobertChief Financial Officer | Sell | 1,094 | $8.18 | $9K |
| Mar 16, 2026 | Shelton JerrellPresident, CEO | Sell | 7,918 | $8.00 | $63K |
| Mar 16, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 3,235 | $8.00 | $26K |
| Mar 16, 2026 | Stefanovich RobertChief Financial Officer | Sell | 2,743 | $8.00 | $22K |
| Mar 16, 2026 | Zecchini Edward JSee Remarks | Sell | 2,014 | $8.00 | $16K |
| Mar 12, 2026 | Stefanovich RobertChief Financial Officer | Sell | 38,700 | $7.76 | $300K |
| Dec 10, 2025 | Mandalam RamkumarDirector | Sell | 11,570 | $9.99 | $116K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance